UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 12 von 52
Datensatz exportieren als...
BibTeX
Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastoma
NMR in biomedicine, 2014-11, Vol.27 (11), p.1333-1345
Delgado-Goñi, Teresa
Julià-Sapé, Margarida
Candiota, Ana Paula
Pumarola, Martí
Arús, Carles
2014
Volltextzugriff (PDF)
Details
Autor(en) / Beteiligte
Delgado-Goñi, Teresa
Julià-Sapé, Margarida
Candiota, Ana Paula
Pumarola, Martí
Arús, Carles
Titel
Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastoma
Ist Teil von
NMR in biomedicine, 2014-11, Vol.27 (11), p.1333-1345
Ort / Verlag
England: Blackwell Publishing Ltd
Erscheinungsjahr
2014
Quelle
Wiley Online Library - AutoHoldings Journals
Beschreibungen/Notizen
Non‐invasive monitoring of response to treatment of glioblastoma (GB) is nowadays carried out using MRI. MRS and MR spectroscopic imaging (MRSI) constitute promising tools for this undertaking. A temozolomide (TMZ) protocol was optimized for GL261 GB. Sixty‐three mice were studied by MRI/MRS/MRSI. The spectroscopic information was used for the classification of control brain and untreated and responding GB, and validated against post‐mortem immunostainings in selected animals. A classification system was developed, based on the MRSI‐sampled metabolome of normal brain parenchyma, untreated and responding GB, with a 93% accuracy. Classification of an independent test set yielded a balanced error rate of 6% or less. Classifications correlated well both with tumor volume changes detected by MRI after two TMZ cycles and with the histopathological data: a significant decrease (p < 0.05) in the proliferation and mitotic rates and a 4.6‐fold increase in the apoptotic rate. A surrogate response biomarker based on the linear combination of 12 spectral features has been found in the MRS/MRSI pattern of treated tumors, allowing the non‐invasive classification of growing and responding GL261 GB. The methodology described can be applied to preclinical treatment efficacy studies to test new antitumoral drugs, and begets translational potential for early response detection in clinical studies. Copyright © 2014 John Wiley & Sons, Ltd. A surrogate response biomarker, based in the linear combination of 12 spectral features, has been found in the MRS/MRSI pattern of GB treated with TMZ. This spectroscopic information has been used to develop a non‐invasive classification system of tumor response to therapy, consistent and applicable to unseen cases. The early response biomarker can be used in future studies for evaluating the interest of new antitumoral drugs.
Sprache
Englisch
Identifikatoren
ISSN: 0952-3480
eISSN: 1099-1492
DOI: 10.1002/nbm.3194
Titel-ID: cdi_proquest_miscellaneous_1622615348
Format
–
Schlagworte
Animals
,
Antineoplastic Agents, Alkylating - administration & dosage
,
Antineoplastic Agents, Alkylating - analysis
,
Antineoplastic Agents, Alkylating - pharmacokinetics
,
Antineoplastic Agents, Alkylating - therapeutic use
,
Apoptosis
,
Brain - metabolism
,
Brain Neoplasms - chemistry
,
Brain Neoplasms - drug therapy
,
Brain Neoplasms - pathology
,
Cell Line, Tumor
,
Dacarbazine - administration & dosage
,
Dacarbazine - analogs & derivatives
,
Dacarbazine - analysis
,
Dacarbazine - pharmacokinetics
,
Dacarbazine - therapeutic use
,
DMSO
,
Drug Administration Schedule
,
Female
,
GL261 glioblastoma
,
Glioblastoma - chemistry
,
Glioblastoma - drug therapy
,
Glioblastoma - pathology
,
Magnetic Resonance Imaging - methods
,
Magnetic Resonance Spectroscopy - methods
,
Metabolome
,
Mice
,
Mice, Inbred C57BL
,
Mitosis
,
pattern recognition
,
Pattern Recognition, Automated
,
perturbation-enhanced MRSI
,
therapy response detection
,
Tumor Burden
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX